CHIPS Act Invests $2 Billion in IBM’s Quantum Superconducting Silicon
The U.S. government is investing significantly in quantum technology through the CHIPS Act, focusing on IBM’s groundbreaking venture. On May 21, 2026, IBM announced a historic initiative to establish Anderon, the first pure-play quantum chip foundry in the United States. This project is backed by a substantial $1 billion from the U.S. Department of Commerce and an equal amount from IBM.
CHIPS Act and Anderon: A Strategic Investment
The $2 billion CHIPS quantum package spreads funding across nine companies, with IBM receiving the largest share to bolster its quantum manufacturing capabilities. The investment is pivotal in making IBM’s 300mm silicon wafer fabrication expertise central to the U.S. quantum strategy.
Investment Breakdown
- IBM (Anderon): $1 billion for infrastructure.
- GlobalFoundries: $375 million for a quantum-focused venture.
- Other Companies: $38 million to $100 million each for research and development.
Anderon will be based in Albany, New York, and will initially focus on superconducting qubits and related electronics. Future plans involve expanding into various quantum technologies.
Superconducting Silicon: The Future of Quantum Computing
IBM’s Anderon aims to leverage superconducting silicon’s advantages over other modalities like trapped ion, photonic, and neutral atom technologies. This fabrication method provides a substantial speed advantage over older 200mm alternatives, making it a vital component of the quantum ecosystem.
Key Advantages of 300mm Fabrication
- 30 times faster device output compared to 200mm facilities.
- Ability to run continuously with advanced automation.
- Support for rapid iterations and improvements in design.
Leading experts, including IBM’s Director of Research, argue that superconducting qubits enable faster advancements, which is crucial for achieving production at scale.
A Two-Tier Quantum Ecosystem
The CHIPS funding structure creates a two-tier system, directing significant resources to superconducting silicon, while other modalities receive smaller equity stakes. This model allows the government to mitigate technology risks, stimulating focused growth in a sector ripe for innovation.
Concerns and Considerations
One critical question remains: will focusing on superconducting silicon potentially hinder other promising technologies? The funding structure suggests a commitment to manufacturing scale for superconducting qubits, but its impact on overall innovation and technology diversity warrants careful monitoring.
Securing the Future of Quantum Development
As this investment unfolds, key areas to observe include:
- The ability of competing quantum companies to secure their own manufacturing infrastructure.
- Progress and development from GlobalFoundries as a second potential 300mm supplier.
- Advancements in IBM’s custom ASIC development to support scalable quantum control.
In conclusion, the CHIPS Act and its significant investment in IBM’s Anderon initiative are set to reshape the landscape of quantum technology in the U.S., laying the groundwork for future leadership in this vital field.




